Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Stelios Papadopoulos

Affiliations

  • Director at Regulus Therapeutics Inc. (RGLS), 2019-10-15
  • Director at Biogen Inc. (BIIB), 2019-06-20
  • Director at Exelixis Inc. (EXEL), 2019-05-25
  • Director at Bg Medicine Inc. (BGMD), 2015-11-20
  • Director at Anadys Pharmaceuticals Inc (ANDS), 2011-05-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RGLS $1.08 370,370 Director 1,189,872 2019-05-07 Filing
RGLS $1.09 50,000 Director 835,073 2018-12-28 Filing
RGLS $1.04 26,401 Director 785,073 2018-12-27 Filing
RGLS $0.95 90,000 Director 758,672 2018-12-26 Filing
RGLS $1.38 300,000 Director 668,672 2018-11-16 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EXEL $21.25 26,250 Director 1,042,251 2019-02-21 Filing
EXEL $22.15 15,000 Director 1,034,314 2018-05-07 Filing
EXEL $24.05 15,000 Director 1,034,314 2018-03-02 Filing
EXEL $25.40 10,000 Director 0 2017-09-22 Filing
EXEL $27.63 127,790 Director 1,034,314 2017-09-19 Filing